Odence-Ford Marion bought OPRX
February 11, 2026 · Form 4 insider transaction
Odence-Ford Marion bought 4,000 shares of OptimizeRx Corporation, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
N/A
Total value
N/A
InsiderOdence-Ford Marion
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after93,322
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.